Encephalitis with Extensive Cortical Brain Magnetic Resonance Imaging Changes Secondary to Myelin Oligodendrocyte Glycoprotein Antibody Disease.
Journal
The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566
Informations de publication
Date de publication:
31 Aug 2022
31 Aug 2022
Historique:
entrez:
31
8
2022
pubmed:
1
9
2022
medline:
9
9
2022
Statut:
epublish
Résumé
BACKGROUND The relatively new autoimmune disorder, anti-myelin oligodendrocyte glycoprotein (MOG) disease is particularly interesting because of its broad range of presentations. This entity's appearance on magnetic resonance imaging (MRI) of the brain often makes identifying this disease a challenging process. Younger patients tend to present with an acute disseminated encephalomyelitis picture, with encephalopathy and multifocal neurological signs, while older patients are more likely to present with optic neuritis. We, however, report an atypical case of a patient who presented with encephalopathy, seizures, and significant cortical and subcortical gray matter involvement and was found to have anti-MOG positivity in serum. CASE REPORT A 17-month-old previously healthy boy presented to Emergency Department with fever, lethargy, vomiting, and left-sided weakness. Eventually, he required intubation due to a prolonged seizure. Continuous electroencephalogram captured several focal seizures, and MRI of the brain showed cortical and subcortical T2 hyperintensities. After extensive laboratory evaluation, he tested positive for anti-MOG antibody. He was empirically started on high-dose intravenous pulse methylprednisolone, followed by plasma exchange, given the poor response to the intravenous steroids. At the 5-month follow-up, the results of the neurological examination had dramatically improved, and MRI findings had largely resolved. CONCLUSIONS This case highlights the importance of suspecting anti-MOG antibody-mediated encephalitis, even while ruling out infectious etiologies, in children presenting with encephalopathy, seizures and MRI abnormalities. Prompt recognition would allow for less delay in treatment and hopefully improve prognosis.
Identifiants
pubmed: 36044392
pii: 936361
doi: 10.12659/AJCR.936361
pmc: PMC9444166
doi:
Substances chimiques
Autoantibodies
0
Myelin-Oligodendrocyte Glycoprotein
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e936361Références
Mult Scler Relat Disord. 2021 Apr;49:102759
pubmed: 33508569
Brain. 2017 Dec 1;140(12):3128-3138
pubmed: 29136091
Neurol Neuroimmunol Neuroinflamm. 2020 May 1;7(4):
pubmed: 32358225
J Neurol Neurosurg Psychiatry. 2015 Mar;86(3):265-72
pubmed: 25121570
J Neurol. 2019 Oct;266(10):2481-2487
pubmed: 31243540
Neurol Neuroimmunol Neuroinflamm. 2017 Jan 16;4(2):e322
pubmed: 28105459
Neurology. 2018 May 22;90(21):e1858-e1869
pubmed: 29695592
Mult Scler. 2020 Jun;26(7):806-814
pubmed: 31094288
Brain. 2020 May 1;143(5):1431-1446
pubmed: 32412053
J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):127-137
pubmed: 29142145
J Neurochem. 1999 Jan;72(1):1-9
pubmed: 9886048
Neurology. 2017 Aug 29;89(9):900-908
pubmed: 28768844
Turk Pediatri Ars. 2020 Dec 16;55(4):449-452
pubmed: 33414667
Mult Scler. 2016 Feb;22(2):174-84
pubmed: 26041801